Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthood

2Citations
Citations of this article
17Readers
Mendeley users who have this article in their library.

Abstract

We have investigated early programming of body mass in order to understand the multifactorial etiology of obesity. Considering that the renin-angiotensin system is expressed and functional in the white adipose tissue (WAT) and modulates its development, we reasoned whether early transitory inhibition of angiotensin-I converting enzyme activity after birth could modify late body mass development. Therefore, newborn Wistar rats were treated with enalapril (10 mg/kg of body mass) or saline, starting at the first day of life until the age of 16 days. Between days 90 th and 180 th, a group of these animals received high fat diet (HFD). Molecular, biochemical, histological and physiological data were collected. Enalapril treated animals presented hyperphagia, overweight and increased serum level of triglycerides, total cholesterol and leptin, in adult life. Body composition analyses revealed higher fat mass with increased adipocyte size in these animals. Molecular analyses revealed that enalapril treatment increases neuropeptide Y (NPY) and cocaine- and amphetamine-regulated transcript (CART) gene expression in hypothalamus, fatty acid synthase (FAS) and hormone-sensitive lipase (HSL) gene expression in retroperitoneal WAT and decreases peroxixome proliferators-activated receptor (PPAR) γ, PPARα, uncoupling protein (UCP) 2 and UCP3 gene expression in WAT. The results of the current study indicate that enalapril administration during early postnatal development increases body mass, adiposity and serum lipids in adulthood associated with enhanced food intake and decreased metabolic activity in WAT, predisposing to obesity in adulthood.

Cite

CITATION STYLE

APA

De Picoli Souza, K., Da Silva, E. D., Batista, E. C., Reis, F. C. G., Silva, S. M. A., Castro, C. H. M., … Pesquero, J. B. (2015). Early pharmacological inhibition of angiotensin-I converting enzyme activity induces obesity in adulthood. Frontiers in Pharmacology, 6(MAR). https://doi.org/10.3389/fphar.2015.00075

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free